Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities
Author:
Affiliation:
1. Department of Dermatology; Seoul National University College of Medicine; Seoul Republic of Korea
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.12080/fullpdf
Reference18 articles.
1. The adjuvant therapy of pemphigus. An update;Bystryn;Arch Dermatol,1996
2. Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity;Culton;J Autoimmun,2008
3. A review of the current use of rituximab in autoimmune diseases;Gurcan;Int Immunopharmacol,2009
4. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL;Heizmann;Am J Hematol,2001
5. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up;Cianchini;J Am Acad Dermatol,2012
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A study of ultralow dose rituximab as adjuvant to standard of care in treatment of significant and extensive pemphigus vulgaris: A case series;Journal of the American Academy of Dermatology;2024-09
2. The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study;Journal of Dermatological Treatment;2024-01-22
3. Is It Time to Reconsider Rituximab Dosing Regimens for Pemphigus Vulgaris?;Antibodies;2024-01-05
4. Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability;Patient Preference and Adherence;2022-11
5. Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris;JAMA Dermatology;2022-09-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3